Evan Birney

Evan Birney is the interim executive director of the European Molecular Biology Laboratory (EMBL), where he leads efforts in molecular biology and bioinformatics research. He has been involved in groundbreaking projects, including the Delphi-2M AI system, which aims to revolutionize personal healthcare by predicting disease risks. Birney’s leadership in EMBL emphasizes the importance of data-driven approaches to improve healthcare outcomes and personalize medical interventions.